(MedPage Today) — SAN FRANCISCO — Descartes-08, an autologous, B-cell maturation antigen (BCMA)-directed mRNA chimeric antigen receptor (CAR) T-cell therapy, led to sustained responses in generalized myasthenia gravis (MG), a phase IIb trial…
Source link : https://www.medpagetoday.com/meetingcoverage/aanem/118230
Author :
Publish date : 2025-10-30 15:36:00
Copyright for syndicated content belongs to the linked Source.
